» Articles » PMID: 25173640

Expression of BTG1 in Hepatocellular Carcinoma and Its Correlation with Cell Cycles, Cell Apoptosis, and Cell Metastasis

Overview
Journal Tumour Biol
Publisher Sage Publications
Specialty Oncology
Date 2014 Sep 1
PMID 25173640
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

This study aimed to analyze the expression, clinical significance of B cell translocation gene 1 (BTG1) in hepatocellular carcinoma, and the biological effect in its cell line by BTG1 overexpression. Immunohistochemistry and Western blot were used to analyze BTG1 protein expression in 70 cases of hepatocellular cancer and 32 cases of normal tissues to study the relationship between BTG1 expression and clinical factors. Recombinant lentiviral vector was constructed to overexpress BTG1 and then infect hepatocellular cancer HepG2 cell line. The level of BTG1 protein expression was found to be significantly lower in hepatocellular cancer tissue than normal tissues (P < 0.05). Decreased expression of BTG1 was significantly correlated with tumor invasion, lymph node metastasis, clinic stage, and histological grade of patients with hepatocellular cancer (P < 0.05). Meanwhile, loss of BTG1 expression correlated significantly with poor overall survival time by Kaplan-Meier analysis (P < 0.05). The result of biological function has shown that HepG2 cell-transfected BTG1 had a lower survival fraction; higher percentage of the G0/G1 phases; higher cell apoptosis; significant decrease in migration and invasion; and lower Cyclin D1 (CND1), B cell lymphoma 2 (Bcl-2), and matrix metalloproteinases (MMP)-9 protein expression compared with HepG2 cell-untransfected BTG1 (P < 0.05). BTG1 expression decreased in hepatocellular cancer and correlated significantly with lymph node metastasis, clinic stage, histological grade, poor overall survival, proliferation, and metastasis in hepatocellular cancer cell by regulating CND1, Bcl-2, and MMP-9 protein expression, suggesting that BTG1 may play important roles as a negative regulator to hepatocellular cancer cell.

Citing Articles

The roles of mRNA expression in cancers: A bioinformatics analysis.

Zheng H, Xue H, Zhang C, Shi K, Zhang R Front Genet. 2022; 13:1006636.

PMID: 36339000 PMC: 9633688. DOI: 10.3389/fgene.2022.1006636.


BTG1 Overexpression Might Promote Invasion and Metastasis of Colorectal Cancer Decreasing Adhesion and Inducing Epithelial-Mesenchymal Transition.

Zhao S, Xue H, Hao C, Jiang H, Zheng H Front Oncol. 2020; 10:598192.

PMID: 33330092 PMC: 7729016. DOI: 10.3389/fonc.2020.598192.


BTG1 inhibits malignancy as a novel prognosis signature in endometrial carcinoma.

Li Y, Huo J, He J, Zhang Y, Ma X Cancer Cell Int. 2020; 20:490.

PMID: 33041670 PMC: 7542768. DOI: 10.1186/s12935-020-01591-3.


Deletion of Btg1 Induces Prmt1-Dependent Apoptosis and Increased Stemness in Shh-Type Medulloblastoma Cells Without Affecting Tumor Frequency.

Ceccarelli M, DAndrea G, Micheli L, Tirone F Front Oncol. 2020; 10:226.

PMID: 32231994 PMC: 7082329. DOI: 10.3389/fonc.2020.00226.


Identification of BTG1 Status in Solid Cancer for Future Researches Using a System Review and Meta-analysis.

Chen X, Meng F, Xiong H, Wang Y, Tang W, Zou Y Curr Med Sci. 2020; 40(1):85-94.

PMID: 32166669 DOI: 10.1007/s11596-020-2150-z.


References
1.
Rouault J, Rimokh R, Tessa C, Paranhos G, Ffrench M, Duret L . BTG1, a member of a new family of antiproliferative genes. EMBO J. 1992; 11(4):1663-70. PMC: 556617. DOI: 10.1002/j.1460-2075.1992.tb05213.x. View

2.
Wiseman B, Werb Z . Stromal effects on mammary gland development and breast cancer. Science. 2002; 296(5570):1046-9. PMC: 2788989. DOI: 10.1126/science.1067431. View

3.
Koff A, Cross F, Fisher A, Schumacher J, LeGuellec K, Philippe M . Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell. 1991; 66(6):1217-28. DOI: 10.1016/0092-8674(91)90044-y. View

4.
Corjay M, Kearney M, Munzer D, Diamond S, Stoltenborg J . Antiproliferative gene BTG1 is highly expressed in apoptotic cells in macrophage-rich areas of advanced lesions in Watanabe heritable hyperlipidemic rabbit and human. Lab Invest. 1998; 78(7):847-58. View

5.
Cortes U, Moyret-Lalle C, Falette N, Duriez C, Ghissassi F, Barnas C . BTG gene expression in the p53-dependent and -independent cellular response to DNA damage. Mol Carcinog. 2000; 27(2):57-64. View